199 related articles for article (PubMed ID: 31121610)
1. Effect of Metformin Treatment on Insulin Resistance Markers, and Circulating Irisin in Women with Polycystic Ovarian Syndrome (PCOS).
Masaeli A; Nayeri H; Mirzaee M
Horm Metab Res; 2019 Sep; 51(9):575-579. PubMed ID: 31121610
[TBL] [Abstract][Full Text] [Related]
2. Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome.
Li M; Yang M; Zhou X; Fang X; Hu W; Zhu W; Wang C; Liu D; Li S; Liu H; Yang G; Li L
J Clin Endocrinol Metab; 2015 Apr; 100(4):1485-93. PubMed ID: 25675380
[TBL] [Abstract][Full Text] [Related]
3. The association between circulating irisin levels and different phenotypes of polycystic ovary syndrome.
Zhang L; Fang X; Li L; Liu R; Zhang C; Liu H; Tan M; Yang G
J Endocrinol Invest; 2018 Dec; 41(12):1401-1407. PubMed ID: 29785700
[TBL] [Abstract][Full Text] [Related]
4. Free androgen index and Irisin in polycystic ovary syndrome.
Li H; Xu X; Wang X; Liao X; Li L; Yang G; Gao L
J Endocrinol Invest; 2016 May; 39(5):549-56. PubMed ID: 26584566
[TBL] [Abstract][Full Text] [Related]
5. Circulating irisin and glucose-dependent insulinotropic peptide are associated with the development of polycystic ovary syndrome.
Chang CL; Huang SY; Soong YK; Cheng PJ; Wang CJ; Liang IT
J Clin Endocrinol Metab; 2014 Dec; 99(12):E2539-48. PubMed ID: 25029417
[TBL] [Abstract][Full Text] [Related]
6. Serum irisin levels in polycystic ovary syndrome after ovarian drilling.
Foda AA; Foda EA; El-Said ZH
Diabetes Metab Syndr; 2019; 13(2):1463-1468. PubMed ID: 31336507
[TBL] [Abstract][Full Text] [Related]
7. Serum irisin and its regulation by hyperinsulinemia in women with polycystic ovary syndrome.
Adamska A; Karczewska-Kupczewska M; Lebkowska A; Milewski R; Górska M; Otziomek E; Nikolajuk A; Wolczynski S; Kowalska I
Endocr J; 2016 Dec; 63(12):1107-1112. PubMed ID: 27616010
[TBL] [Abstract][Full Text] [Related]
8. Serum irisin levels in patients with polycystic ovary syndrome.
Bostancı MS; Akdemir N; Cinemre B; Cevrioglu AS; Özden S; Ünal O
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4462-8. PubMed ID: 26698239
[TBL] [Abstract][Full Text] [Related]
9. Serum and follicular fluid irisin levels in women with polycystic ovaries undergoing ovarian stimulation: correlation with insulin resistance and lipoprotein lipid profiles.
Bousmpoula A; Benidis E; Demeridou S; Kapeta-Kourkouli R; Chasiakou A; Chasiakou S; Kouskouni E; Baka S
Gynecol Endocrinol; 2019 Sep; 35(9):803-806. PubMed ID: 30982370
[TBL] [Abstract][Full Text] [Related]
10. Higher circulating irisin levels in patients with polycystic ovary syndrome:a meta-analysis.
Wang C; Zhang XY; Sun Y; Hou XG; Chen L
Gynecol Endocrinol; 2018 Apr; 34(4):290-293. PubMed ID: 29069945
[TBL] [Abstract][Full Text] [Related]
11. Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters.
Pirwany IR; Fleming R; Greer IA; Packard CJ; Sattar N
Clin Endocrinol (Oxf); 2001 Apr; 54(4):447-53. PubMed ID: 11318779
[TBL] [Abstract][Full Text] [Related]
12. Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment.
Heutling D; Schulz H; Nickel I; Kleinstein J; Kaltwasser P; Westphal S; Mittermayer F; Wolzt M; Krzyzanowska K; Randeva H; Schernthaner G; Lehnert H
J Clin Endocrinol Metab; 2008 Jan; 93(1):82-90. PubMed ID: 17986642
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study.
Kilicdag EB; Bagis T; Zeyneloglu HB; Tarim E; Aslan E; Haydardedeoglu B; Erkanli S
Hum Reprod; 2005 Apr; 20(4):894-9. PubMed ID: 15618250
[TBL] [Abstract][Full Text] [Related]
14. Decreased Circulating MANF in Women with PCOS is Elevated by Metformin Therapy and is Inversely Correlated with Insulin Resistance and Hyperandrogenism.
Wei J; Wang C; Yang G; Jia Y; Li Y; Deng W; Long M; Wang C; Liu D
Horm Metab Res; 2020 Feb; 52(2):109-116. PubMed ID: 32067218
[TBL] [Abstract][Full Text] [Related]
15. Implications of circulating irisin and Fabp4 levels in patients with polycystic ovary syndrome.
Abali R; Temel Yuksel I; Yuksel MA; Bulut B; Imamoglu M; Emirdar V; Unal F; Guzel S; Celik C
J Obstet Gynaecol; 2016 Oct; 36(7):897-901. PubMed ID: 27184575
[TBL] [Abstract][Full Text] [Related]
16. Serum irisin concentrations in lean adolescents with polycystic ovary syndrome.
Bacopoulou F; Athanasopoulos N; Efthymiou V; Mantzou A; Aravantinos L; Vlahopoulos S; Deligeoroglou E
Clin Endocrinol (Oxf); 2018 Apr; 88(4):585-591. PubMed ID: 29368340
[TBL] [Abstract][Full Text] [Related]
17. Abnormal irisin level in serum and endometrium is associated with metabolic dysfunction in polycystic ovary syndrome patients.
Wang W; Guo Y; Zhang X; Zheng J
Clin Endocrinol (Oxf); 2018 Oct; 89(4):474-480. PubMed ID: 29972694
[TBL] [Abstract][Full Text] [Related]
18. Effects of metformin on serum insulin and anti-Mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome.
Nascimento AD; Silva Lara LA; Japur de Sá Rosa-e-Silva AC; Ferriani RA; Reis RM
Gynecol Endocrinol; 2013 Mar; 29(3):246-9. PubMed ID: 23194004
[TBL] [Abstract][Full Text] [Related]
19. Effects of Short Term Metformin Treatment on Brown Adipose Tissue Activity and Plasma Irisin Levels in Women with Polycystic Ovary Syndrome: A Randomized Controlled Trial.
Oliveira FR; Mamede M; Bizzi MF; Rocha ALL; Ferreira CN; Gomes KB; Cândido AL; Reis FM
Horm Metab Res; 2020 Oct; 52(10):718-723. PubMed ID: 32365398
[TBL] [Abstract][Full Text] [Related]
20. Intrinsic factors rather than vitamin D deficiency are related to insulin resistance in lean women with polycystic ovary syndrome.
Sahin S; Eroglu M; Selcuk S; Turkgeldi L; Kozali S; Davutoglu S; Muhcu M
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2851-6. PubMed ID: 25339479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
